SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004086
Filing Date
2021-11-10
Accepted
2021-11-10 16:16:08
Documents
92
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fdmt-20210930.htm   iXBRL 10-Q 3249915
2 EX-10.4 fdmt-ex10_4.htm EX-10.4 126352
3 EX-31.1 fdmt-ex31_1.htm EX-31.1 22616
4 EX-31.2 fdmt-ex31_2.htm EX-31.2 22542
5 EX-32.1 fdmt-ex32_1.htm EX-32.1 14415
  Complete submission text file 0000950170-21-004086.txt   11166562

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fdmt-20210930.xsd EX-101.SCH 76888
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fdmt-20210930_pre.xml EX-101.PRE 433522
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fdmt-20210930_lab.xml EX-101.LAB 538985
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fdmt-20210930_cal.xml EX-101.CAL 40623
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fdmt-20210930_def.xml EX-101.DEF 266398
11 EXTRACTED XBRL INSTANCE DOCUMENT fdmt-20210930_htm.xml XML 2034358
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39782 | Film No.: 211396828
SIC: 2836 Biological Products, (No Diagnostic Substances)